Back

Thrombocheck: a drug-drug interactions guide for cardiologists prescribing antithrombotic therapy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Optimising cardiovascular care through multidisciplinary approaches and pharmacological strategies Allied Professions in Cardiovascular Care ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Alma Feka

Lausanne University Hospital, Lausanne (Switzerland)

5 More presentations in this session

Presentation thumbnail
Impact of a pharmacist-led clinic in optimising lipid therapy for post-acute coronary syndromes (ACS) in high risk cardiovascular patients.
Mr M. Hart (Newcastle Upon Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Multidisciplinary approach integrating clinical cardiology and clinical pharmacology to optimize guideline-directed medical therapy in elective cardiac surgery patients
Doctor M. Verdugo-Marchese (Gland, CH)
Abstract Slides Video
Presentation thumbnail
Economic impact of pharmacist-led clinical interventions in a cardiac intensive care unit
Ms M. Lim (Clayton, AU)
Abstract Slides Video
Presentation thumbnail
The active role of nursing in the diagnosis of chagas cardiomyopathy within a multidisciplinary team: experience in Mexico
Mr J. Gonzalez Lopez (Guadalajara, MX)
Abstract Slides Video
Presentation thumbnail
Preoperative nurse consultation as a key component of perioperative optimization in elective cardiac surgery patients
Ms V. Melly (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising cardiovascular care through multidisciplinary approaches and pharmacological strategies
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants in ambulatory care: a prospective interventional study in community pharmacies
thumbnail
Congress Presentation
Drug interactions in incident NOACs users and risk of bleeding
thumbnail
Congress Presentation
Pharmacodynamic and pharmacokinetic profiles associated with switching from cangrelor to prasugrel in patients undergoing percutaneous coronary intervention: the SWAP-6 study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources